Join
Live feed
·
INSIDERFilingvia Quantisnow
Cyclerion Therapeutics Inc. logo

SEC Form 4: Slate Path Capital LP bought $2,999,999 worth of Common Stock (961,538 units at $3.12)

ByQuantisnow·Wall Street's wire, on your screen.
CYCN· Cyclerion Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CYCN (Cyclerion Therapeutics Inc.) and more on Quantisnow.